NCT05958823

Brief Summary

The effects of anterior chest wall blocks (PECS and SAP will be used in this study) performed for postoperative analgesia on pain scores (to be checked with visual analogue scale (VAS), opioid consumption, length of hospital stay, mobilization time, side effects and complications in the postoperative period will be examined.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
243

participants targeted

Target at P75+ for not_applicable postoperative-pain

Timeline
Completed

Started Jun 2023

Typical duration for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2023

Completed
23 days until next milestone

Study Start

First participant enrolled

June 15, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 25, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 26, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

March 3, 2026

Status Verified

February 1, 2026

Enrollment Period

11 months

First QC Date

May 23, 2023

Last Update Submit

February 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Duration of Mechanical Ventilation

    Time (in hours) from ICU admission to successful extubation.

    Within the first 24 postoperative hours

Secondary Outcomes (6)

  • Length of Intensive Care Unit (ICU) Stay

    Assessed once at the time of ICU discharge, measured as total hours from ICU admission to ICU discharge (expected within 30 postoperative days).

  • Postoperative Pain Intensity at Rest (VAS)

    Assessed at 0, 4, 8, 12, and 24 hours after extubation within the first 24 hours post-extubation.

  • Total Rescue Opioid Consumption (Morphine Equivalents)

    Within the first 24 hours after extubation

  • Time to First Mobilization

    Assessed once when first active sitting at bedside is achieved, within 48 hours after ICU admission.

  • Postoperative Nausea and Vomiting (PONV)

    Assessed at 0-24, 24-48, and 48-72 hours after extubation during postoperative ICU and ward follow-up.

  • +1 more secondary outcomes

Study Arms (3)

Group S - Serratus Anterior Plane Block

EXPERIMENTAL

Patients received an ultrasound-guided serratus anterior plane (SAP) block with 30 mL of 0.25% bupivacaine within the first 30 minutes after ICU admission in addition to standardized systemic analgesia.

Procedure: Serratus anterior plane block

Group P - Pectoral Nerve Block (PECS I-II)

EXPERIMENTAL

Patients received ultrasound-guided PECS I-II block with a total of 30 mL of 0.25% bupivacaine within the first 30 minutes after ICU admission in addition to standardized systemic analgesia.

Procedure: PECS I-II

Group C - Standard Systemic Analgesia

ACTIVE COMPARATOR

Patients received standardized multimodal systemic analgesia without any regional block. Postoperative analgesia consisted of scheduled intravenous paracetamol and rescue opioid administration as needed.

Other: Standard Systemic Analgesia

Interventions

Standard postoperative multimodal systemic analgesia without regional nerve block. Postoperative analgesia includes scheduled intravenous paracetamol and rescue opioid administration as needed.

Group C - Standard Systemic Analgesia

Serratus anterior plane block

Group S - Serratus Anterior Plane Block
PECS I-IIPROCEDURE

PECS I-II

Group P - Pectoral Nerve Block (PECS I-II)

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Agreeing to participate in the study,
  • years old
  • ASA I-II-III
  • Open heart surgery

You may not qualify if:

  • Refusal to participate in the study
  • years old, over 65 years old
  • Pregnancy
  • Presence of bleeding diathesis
  • Liver or kidney failure
  • Receiving effective treatment on immunity
  • Immune suppressed
  • Those with BMI ≥30

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Van Yuzuncu Yil University

Van, Turkey, 65100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, PostoperativePostoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • School of Medicine Department of Anesthesiology and Reanimation

    Yuzuncu Yil University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants and outcome assessors were blinded to group allocation. The anesthesiologist performing the regional block was not blinded. ICU clinicians responsible for extubation decisions were unaware of treatment allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, randomized, parallel-group, controlled clinical trial with three arms.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 23, 2023

First Posted

July 25, 2023

Study Start

June 15, 2023

Primary Completion

April 26, 2024

Study Completion

November 1, 2024

Last Updated

March 3, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

participiants's personal information will not be shared anyone

Locations